Synergistic interaction between thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide and sorafenib in liver cancer cells
Publication date: Available online 19 March 2020Source: Hepatobiliary & Pancreatic Diseases InternationalAuthor(s): Lin-Ping Cao, Chen Zhang, Xiao-Yu Weng, Hai-Yang Xie, Jian Wu, Shu-Sen Zheng
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Liver | Pancreas | Pancreatic Cancer | Urology & Nephrology